NAD+ IV therapy occupies a compliance gray zone most malpractice carriers and state boards are still catching up to. Pick the wrong medical director for NAD+ IV therapy and the clinic, not the nurse holding the bag, absorbs the liability in 2026.
- The right medical director for NAD+ IV therapy clinics pairs a collaborating physician agreement with infusion-specific standing orders. Buy that model.
- Generalist telehealth medical directors with no IV infusion protocol experience are a common shortcut. Skip them.
- Good faith exams before a patient’s first NAD+ infusion are required in most states running aesthetic or wellness IV programs.
- Mobile NAD+ IV operators need oversight structured around the state where the patient sits, not where the nurse lives.
- US Medical Directors covers medspa, IV therapy, and nurse injector teams across many states with bulk pricing for growing groups.
Why this matters
NAD+ infusions moved from biohacker fringe to mainstream medspa menu fast, and most states never wrote rules specifically for it. Regulators default to whatever they already have on the books for IV therapy, hormone therapy, and medspa oversight generally — a NAD+ clinic without a medical director operates under the same corporate-practice-of-medicine and scope-of-practice rules as a Botox injector or a testosterone clinic, just with less clarity about which set applies. US Medical Directors runs oversight programs built around exactly this ambiguity, for medspa, IV therapy, and nurse injector teams across many states.
That ambiguity cuts against clinics that skip oversight, not for them. A malpractice claim or a board complaint after an adverse reaction — dizziness, chest tightness, a vein blown mid-infusion — gets reviewed against whatever standard of care existed for the nurse administering it. No collaborating physician, no standing orders, no chart review trail means no defense in 2026, and that's not a hypothetical regulators are still debating.
Who this is for
This guide is for medspa owners adding NAD+ drips to an existing injectable menu, standalone IV hydration bars building out a NAD+ line, mobile IV businesses running infusions in homes and hotel rooms, and wellness or longevity clinics stacking NAD+ alongside peptide and hormone protocols. If you're a nurse practitioner or RN administering NAD+ without a physician relationship on file, this applies to you directly, not just to the owner signing the checks.
What to look for in a medical director for NAD+ IV therapy
State-specific scope of practice for IV infusion therapy
NAD+ isn't a controlled substance in most states, but ordering an IV infusion typically still requires a physician order or a nurse practitioner acting under a collaborating physician agreement. A medical director who hasn't reviewed your state's specific rules for IV therapy delegation is guessing, and guessing is how a clinic ends up with an unenforceable standing order.
Good faith exam coverage before the first infusion
Most states that regulate aesthetic and wellness IV therapy require a good faith exam before treatment begins — a documented, in-person or synchronous telehealth evaluation confirming the patient is a safe candidate. Confirm your medical director actually performs or delegates these exams instead of treating them as a formality.
Standing orders written for infusion therapy, not injectables
A standing order drafted for Botox and filler doesn't cover dosing ranges, contraindications, or adverse-reaction protocols for an IV drip. Ask to see the actual document before signing — if NAD+ isn't named specifically, it isn't covered, no matter what the sales pitch implies.
Chart review cadence and turnaround
Chart review is the paper trail regulators pull first in an investigation. A medical director who reviews charts once a quarter leaves months of infusions undocumented from a compliance standpoint. A 30-day review cycle or tighter is the standard worth asking for by name.
Multi-state or mobile-ready coverage
If NAD+ infusions happen across state lines — mobile IV routes, multiple clinic locations, or telehealth intake — oversight has to match every state the needle actually enters, not just the one where the business is registered.
Get medical director coverage for NAD+ IV
Compare collaborating physician options built for infusion and wellness clinics.
Oversight models for NAD+ IV therapy clinics
The safe pick: dedicated collaborating physician with infusion-specific standing orders
A physician who signs a collaborating agreement naming NAD+ IV therapy specifically, with standing orders covering dosing ranges, contraindications like pregnancy and certain cardiac conditions, and an adverse-reaction protocol. This is the model regulators expect to see in 2026 for any clinic running infusion therapy under nurse or NP administration, and it mirrors what a medical director for IV hydration clinics already covers. Verdict: Buy.
The scale pick: multi-state oversight for mobile or multi-location NAD+ brands
If infusions happen in a client's living room or across three states, oversight needs a physician, or physician network, licensed everywhere the needle goes in. This costs more than a single-location agreement, but it's the only structure that survives an audit for mobile IV therapy businesses. Verdict: Consider.
The generalist pick: telehealth medical director with no infusion protocol
Some collaborating physician networks sell a flat-rate telehealth arrangement built for injectables and never touch IV infusion dosing at all. It's cheap and it looks compliant on paper until a chart review turns up standing orders that don't mention NAD+ anywhere. Verdict: Skip.
The handshake pick: informal oversight from a friend or family physician
A physician relative or a local doctor who agrees to sign paperwork without reviewing protocols, without scheduled chart review, and without malpractice coverage tied to the arrangement. It satisfies a license lookup for about as long as nobody asks a follow-up question. Verdict: Skip.
“A good faith exam isn’t optional paperwork — it’s the one document that makes everything after it legally defensible.”
What to avoid
- A standing order that never names NAD+. Generic "aesthetic services" language doesn't hold up if a board asks which protocol covered the infusion in question.
- A medical director who can't produce a chart review log. Real oversight leaves a document trail — dates, notes, corrections — not a verbal assurance that everything's fine.
- A physician licensed only in your registration state when you run mobile or multi-state. The physician has to be licensed where the patient receives the infusion, not just where the LLC is filed.
Verdict comparison
| Oversight model | Standing orders for infusion | Multi-state ready | Good faith exams included | Verdict |
|---|---|---|---|---|
| Dedicated collaborating physician | Yes, NAD+-specific | No, single state | Usually | Buy |
| Multi-state / bulk collaborating plan | Yes | Yes | Usually | Consider |
| Generalist telehealth medical director | Rarely | Sometimes | Rarely | Skip |
| Informal / handshake physician | No | No | No | Skip |
FAQ
What does a medical director do for a NAD+ IV therapy clinic?
A medical director signs the collaborating agreement, writes or approves standing orders for NAD+ dosing and contraindications, and reviews charts on a set schedule. In most states this relationship is what allows a nurse or NP to legally order and administer the infusion.
Is a physician required to oversee NAD+ IV infusions?
Yes in the large majority of states, either directly or through a nurse practitioner acting under a collaborating physician agreement. The exact structure depends on state scope-of-practice rules for IV therapy.
How much does medical director oversight cost for an IV therapy clinic in 2026?
Cost varies by state, patient volume, and whether good faith exams and chart review are bundled in. Bulk or multi-provider plans typically bring the per-provider cost down for growing teams.
Can a nurse practitioner order NAD+ IV therapy without a collaborating physician?
In most states, no — an NP administering or ordering IV infusion therapy needs a signed collaborating physician agreement covering that specific service. A handful of full-practice-authority states are the exception.
Do mobile NAD+ IV businesses need different oversight than a storefront clinic?
Yes. Mobile operators need a physician licensed in every state where infusions actually happen, not just where the business is registered, which usually means a multi-state or bulk collaborating plan.
How often should a medical director review NAD+ IV therapy charts?
A 30-day review cycle is the practical standard for infusion therapy, tighter than the quarterly cadence some generalist programs default to. Faster review shortens the gap regulators can flag in an audit.
What’s the difference between a medical director and a collaborating physician for NAD+ clinics?
A medical director oversees clinical protocols and compliance across the practice, while a collaborating physician is the specific physician relationship an NP operates under for patient care. One person or firm often fills both roles for a single clinic.
Is a good faith exam required before a patient’s first NAD+ infusion?
Most states regulating aesthetic and wellness IV therapy require a good faith exam before the first treatment. It documents that a qualified provider evaluated the patient as a safe candidate before any infusion started.
One last thing
The most common compliance gap on NAD+ programs isn't the physician relationship itself — it's silence about dosing. Boards investigating adverse events pull the standing order first, and "NAD+ per clinic protocol" without a documented range gets treated the same as no order at all in 2026. Name the dose range, name the contraindications, and the rest of the file tends to hold up.
Related guides
